BS
Boenning & Scattergood Portfolio holdings
AUM
$622M
This Quarter Return
+11.62%
1 Year Return
-8.78%
3 Year Return
+34.58%
5 Year Return
–
10 Year Return
–
AUM
$334M
AUM Growth
+$334M
(+17%)
Cap. Flow
+$13.1M
Cap. Flow
% of AUM
3.91%
Top 10 Holdings %
Top 10 Hldgs %
23.72%
Holding
289
New
27
Increased
129
Reduced
88
Closed
9
Top Buys
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
$2.46M |
| 2 |
Wells Fargo
WFC
|
$1.56M |
| 3 |
Target
TGT
|
$1.48M |
| 4 |
CVS Health
CVS
|
$1.46M |
| 5 |
Walt Disney
DIS
|
$1.29M |
Top Sells
| 1 |
UHT
Universal Health Realty Income Trust
UHT
|
$5.46M |
| 2 |
iShares Biotechnology ETF
IBB
|
$1.13M |
| 3 |
GSK
GSK
|
$977K |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$703K |
| 5 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
$702K |
Sector Composition
| 1 | Healthcare | 16.34% |
| 2 | Technology | 13% |
| 3 | Industrials | 10.2% |
| 4 | Financials | 9.85% |
| 5 | Energy | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$427B
| $13.2M | 3.96% | 94,480 -1,592 | -2% | -$223K |
|
2
Apple
AAPL
$3.45T
| $10.1M | 3.01% | 52,957 +4,355 | +9% | +$827K |
|
3
Exxon Mobil
XOM
$487B
| $9.96M | 2.98% | 123,282 -6,720 | -5% | -$543K |
|
4
Microsoft
MSFT
$3.77T
| $8.52M | 2.55% | 72,241 +4,573 | +7% | +$539K |
|
5
PepsiCo
PEP
$204B
| $6.79M | 2.03% | 55,393 -1,234 | -2% | -$151K |
|
6
AT&T
T
$209B
| $6.64M | 1.99% | 211,777 +37,971 | +22% | +$1.19M |
|
7
Berkshire Hathaway Class B
BRK.B
$1.09T
| $6.49M | 1.94% | 32,295 +1,389 | +4% | +$279K |
|
8
JPMorgan Chase
JPM
$829B
| $6.27M | 1.88% | 61,959 +11,134 | +22% | +$1.13M |
|
9
Verizon
VZ
$186B
| $6.2M | 1.86% | 104,848 -1,672 | -2% | -$98.9K |
|
10
Home Depot
HD
$405B
| $5.08M | 1.52% | 26,458 +1,227 | +5% | +$235K |
|
11
AbbVie
ABBV
$372B
| $4.95M | 1.48% | 61,468 +15,857 | +35% | +$1.28M |
|
12
Procter & Gamble
PG
$368B
| $4.61M | 1.38% | 44,303 +197 | +0.4% | +$20.5K |
|
13
Alphabet (Google) Class C
GOOG
$2.58T
| $4.54M | 1.36% | 3,868 +446 | +13% | +$523K |
|
14
Abbott
ABT
$231B
| $4.37M | 1.31% | 54,624 +346 | +0.6% | +$27.7K |
|
15
Chevron
CVX
$324B
| $4.27M | 1.28% | 34,649 +1,600 | +5% | +$197K |
|
|
16
CVS Health
CVS
$92.8B
| $4.09M | 1.22% | 75,828 +27,074 | +56% | +$1.46M |
|
17
Becton Dickinson
BDX
$55.3B
| $3.98M | 1.19% | 15,946 +1,000 | +7% | +$250K |
|
18
IBM
IBM
$227B
| $3.55M | 1.06% | 25,145 -1,731 | -6% | -$244K |
|
19
Enterprise Products Partners
EPD
$69.6B
| $3.4M | 1.02% | 116,947 +15,529 | +15% | +$452K |
|
20
Pfizer
PFE
$141B
| $3.36M | 1.01% | 79,091 -1,896 | -2% | -$80.5K |
|
21
Emerson Electric
EMR
$74.3B
| $3.34M | 1% | 48,813 +233 | +0.5% | +$16K |
|
|
22
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $3.32M | 0.99% | 81,141 +60,267 | +289% | +$2.46M |
|
23
Honeywell
HON
$139B
| $3.21M | 0.96% | 20,174 +387 | +2% | +$61.5K |
|
24
Merck
MRK
$210B
| $2.95M | 0.88% | 35,424 -223 | -0.6% | -$18.5K |
|
25
McDonald's
MCD
$224B
| $2.9M | 0.87% | 15,282 +486 | +3% | +$92.3K |
|